Literature DB >> 30448284

The role of monogenic genes in idiopathic Parkinson's disease.

Xylena Reed1, Sara Bandrés-Ciga1, Cornelis Blauwendraat1, Mark R Cookson2.   

Abstract

In the past two decades, mutations in multiple genes have been linked to autosomal dominant or recessive forms of monogenic Parkinson's disease (PD). Collectively, these monogenic (often familial) cases account for less than 5% of all PD, the majority being apparently sporadic cases. More recently, large-scale genome-wide association studies have identified over 40 loci that increase risk of PD. Importantly, there is overlap between monogenic and sporadic PD genes, particularly for the loci that contain the genes SNCA and LRRK2, which are mutated in monogenic dominant PD. There have also been reports of idiopathic PD cases with heterozygous variants in autosomal recessive genes suggesting that these mutations may increase risk of PD. These observations suggest that monogenic and idiopathic PD may have shared pathogenic mechanisms. Here, we focus mainly on the role of monogenic PD genes that represent pleomorphic risk loci for idiopathic PD. We also discuss the functional mechanisms that may play a role in increasing risk of disease in both monogenic and idiopathic forms. Published by Elsevier Inc.

Entities:  

Keywords:  Functional genomics; Genetic risk factors; Idiopathic Parkinson’s disease; Pleomorphic risk loci

Mesh:

Year:  2018        PMID: 30448284      PMCID: PMC6363864          DOI: 10.1016/j.nbd.2018.11.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  148 in total

1.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

2.  MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).

Authors:  Robert Haussmann; Marek Wysocki; Moritz D Brandt; Andreas Hermann; Markus Donix
Journal:  Int Psychogeriatr       Date:  2016-12-01       Impact factor: 3.878

Review 3.  The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.

Authors:  David N Hauser; Christopher T Primiani; Mark R Cookson
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

4.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

Authors:  Roy N Alcalay; Oren A Levy; Cheryl C Waters; Stanley Fahn; Blair Ford; Sheng-Han Kuo; Pietro Mazzoni; Michael W Pauciulo; William C Nichols; Ziv Gan-Or; Guy A Rouleau; Wendy K Chung; Pavlina Wolf; Petra Oliva; Joan Keutzer; Karen Marder; Xiaokui Zhang
Journal:  Brain       Date:  2015-06-27       Impact factor: 13.501

Review 5.  Deciphering the role of heterozygous mutations in genes associated with parkinsonism.

Authors:  Christine Klein; Katja Lohmann-Hedrich; Ekaterina Rogaeva; Michael G Schlossmacher; Anthony E Lang
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

6.  PARK6-linked parkinsonism occurs in several European families.

Authors:  Enza Maria Valente; Francesco Brancati; Alessandro Ferraris; Elizabeth A Graham; Mary B Davis; Monique M B Breteler; Thomas Gasser; Vincenzo Bonifati; Anna Rita Bentivoglio; Giuseppe De Michele; Alexandra Dürr; Pietro Cortelli; Dietmar Wassilowsky; Biswadjiet S Harhangi; Nina Rawal; Viviana Caputo; Alessandro Filla; Giuseppe Meco; Ben A Oostra; Alexis Brice; Alberto Albanese; Bruno Dallapiccola; Nicholas W Wood
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

7.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

8.  Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus.

Authors:  Cornelis Blauwendraat; Jose M Bras; Mike A Nalls; Patrick A Lewis; Dena G Hernandez; Andrew B Singleton
Journal:  Mov Disord       Date:  2018-10-09       Impact factor: 10.338

9.  Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

Authors:  Suzanne Lesage; Valérie Drouet; Elisa Majounie; Vincent Deramecourt; Maxime Jacoupy; Aude Nicolas; Florence Cormier-Dequaire; Sidi Mohamed Hassoun; Claire Pujol; Sorana Ciura; Zoi Erpapazoglou; Tatiana Usenko; Claude-Alain Maurage; Mourad Sahbatou; Stefan Liebau; Jinhui Ding; Basar Bilgic; Murat Emre; Nihan Erginel-Unaltuna; Gamze Guven; François Tison; Christine Tranchant; Marie Vidailhet; Jean-Christophe Corvol; Paul Krack; Anne-Louise Leutenegger; Michael A Nalls; Dena G Hernandez; Peter Heutink; J Raphael Gibbs; John Hardy; Nicholas W Wood; Thomas Gasser; Alexandra Durr; Jean-François Deleuze; Meriem Tazir; Alain Destée; Ebba Lohmann; Edor Kabashi; Andrew Singleton; Olga Corti; Alexis Brice
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

10.  Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe.

Authors:  Cornelis Blauwendraat; Margherita Francescatto; J Raphael Gibbs; Iris E Jansen; Javier Simón-Sánchez; Dena G Hernandez; Allissa A Dillman; Andrew B Singleton; Mark R Cookson; Patrizia Rizzu; Peter Heutink
Journal:  Genome Med       Date:  2016-06-10       Impact factor: 11.117

View more
  34 in total

1.  DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1.

Authors:  Yi Liu; Xiaopin Ma; Hisashi Fujioka; Jun Liu; Shengdi Chen; Xiongwei Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 2.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

Review 3.  Role of Astrocytes in Manganese Neurotoxicity Revisited.

Authors:  Tao Ke; Marta Sidoryk-Wegrzynowicz; Edward Pajarillo; Asha Rizor; Félix Alexandre Antunes Soares; Eunsook Lee; Michael Aschner
Journal:  Neurochem Res       Date:  2019-09-30       Impact factor: 3.996

4.  Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms.

Authors:  Michael A Lodato; Christopher A Walsh
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

Review 5.  LRRK2 links genetic and sporadic Parkinson's disease.

Authors:  Jillian H Kluss; Adamantios Mamais; Mark R Cookson
Journal:  Biochem Soc Trans       Date:  2019-03-05       Impact factor: 5.407

Review 6.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 7.  The role of Rab GTPases in the pathobiology of Parkinson' disease.

Authors:  Luis Bonet-Ponce; Mark R Cookson
Journal:  Curr Opin Cell Biol       Date:  2019-05-01       Impact factor: 8.382

Review 8.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02

9.  Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.

Authors:  Judit Pallos; Sophia Jeng; Shannon McWeeney; Ian Martin
Journal:  Neurobiol Dis       Date:  2021-05-11       Impact factor: 5.996

10.  Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.

Authors:  Justyna Okarmus; Jesper F Havelund; Matias Ryding; Sissel I Schmidt; Helle Bogetofte; Rachel Heon-Roberts; Richard Wade-Martins; Sally A Cowley; Brent J Ryan; Nils J Færgeman; Poul Hyttel; Morten Meyer
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.